Dow 
1.48% Nasdaq 1.73%
1.48% Nasdaq 1.73%Nov 27: 10.51 0.23 (2.14%)
0.23 (2.14%) InterMune Inc. (ITMN)
Compare ITMN to:
- Dow Jones (^DJI)
- NASDAQ (^IXIC)
- S&P 500 (^GSPC)
InterMune, Inc.
(NasdaqGS: ITMN)After Hours: 10.5079 N/A (N/A) 1:17pm ET
| Last Trade: | 10.51 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | 0.23 (2.14%) |
| Prev Close: | 10.74 |
| Open: | 10.55 |
| Bid: | 6.81 x 100 |
| Ask: | N/A |
| 1y Target Est: | 20.75 |
| Day's Range: | 10.48 - 10.81 |
|---|---|
| 52wk Range: | 8.66 - 19.12 |
| Volume: | 172,933 |
| Avg Vol (3m): | 405,928 |
| Market Cap: | 490.49M |
| P/E (ttm): | N/A |
| EPS (ttm): | -2.64 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. For consolidated real-time quotes (incl. pre/post market data), sign up for a free trial of Real-time Quotes.
Headlines
| Sat 10:23am | Less Toxic Monoclonal Antibodies And Increased Patent Protection For Biologics Creates Multiple Positive Investment Scenarios In Biotechnology SectorWall Street Transcript |
| Tue, Nov 17 | [$$] Activity Jumps in Biotech and Drug Firmsat The Wall Street Journal Online |
| Tue, Nov 17 | [$$] Pacific Sunwear and Sunpower Fallat The Wall Street Journal Online |
| Tue, Nov 17 | InterMune Shares Fall on Drug Studyat Fox Business |
| Tue, Nov 17 | Biotech Stocks: Alkermes gains; Cerus, InterMune tumbleat MarketWatch |
| Tue, Nov 17 | UPDATE - InterMune to modify hep C study to drop one dosageat Reuters |
| Tue, Nov 17 | InterMune shares fall on change in hepatitis studyAP |
| Tue, Nov 17 | Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzzat TheStreet.com |
| Tue, Nov 17 | INTERMUNE INC Files SEC form 8-K, Other EventsEDGAR Online |
| Tue, Nov 17 | InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzzat TheStreet.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.